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Alcohol produces both stimulant and sedative ef-
fects in humans and rodents. In humans, alcohol
abuse disorder is associated with a higher stimulant
and lower sedative responses to alcohol. Here, we
show that this association is conserved in mice and
demonstrate a causal link with another liability factor:
low expression of striatal dopamine D2 receptors
(D2Rs). Using transgenic mouse lines, we find that
the selective loss of D2Rs on striatal medium spiny
neurons enhances sensitivity to ethanol stimulation
and generates resilience to ethanol sedation. These
mice also display higher preference and escalation
of ethanol drinking, which continues despite adverse
outcomes. We find that striatal D1R activation is
required for ethanol stimulation and that this
signaling is enhanced in mice with low striatal
D2Rs. These data demonstrate a link between two
vulnerability factors for alcohol abuse and offer evi-
dence for a mechanism in which low striatal D2Rs
trigger D1R hypersensitivity, ultimately leading to
compulsive-like drinking.
INTRODUCTION
Alcohol use disorder (AUD) is a chronic relapsing disease char-
acterized by escalating alcohol drinking and loss of control
over consumption, which leads to compulsive alcohol use
(Koob and Volkow, 2010, 2016). The diagnosis of AUD requires
that individuals meet 2 of the 11 criteria detailed in theDiagnostic
and Statistical Manual of Mental Disorders-V (DSM-V; Grant
et al., 2015). It is unclear why only a proportion of individuals
who consume alcohol developed AUD. Genetic factors account
for approximately half of the risk for developing AUD, and envi-
ronmental interactions are thought to contribute the remainderThis is an open access article under the CC BY-Nof the risk (Reilly et al., 2017). While multiple genes and traits
have been associated with AUD, the mechanisms underlying
vulnerability are unknown and, as a consequence, AUD treat-
ments are unreliable.
Two factors are well known to confer vulnerability for AUD. The
quality and magnitude of the acute response to alcohol are pre-
dictive of alcohol abuse. High stimulation and low sedation in
response to alcohol are known to predispose individuals toward
abuse (Erblich and Earleywine, 2003; Holdstock et al., 2000; King
et al., 2011, 2016). Rodents have proven to be good animal
models for ethanol-induced stimulation and allow for cellular
and molecular analysis of the underlying striatal mechanisms
(Becker and Ron, 2014; Lovinger and Alvarez, 2017). While the
perceived stimulant effects of alcohol are linked to striatal activ-
ity (Weafer et al., 2018), the neurobiology underlying ethanol
stimulation and driving the association with abuse is poorly
understood.
In addition to the stimulant effects of ethanol, low levels of
dopamine D2 receptor (D2R) availability in the striatum is a com-
mon feature associated with addictive disorders, including AUD
(Hietala et al., 1994; Tupala et al., 2001; Volkow et al., 2002; Vol-
kow and Morales, 2015). This raises the possibility that a low
level of striatal D2R is a predisposing factor for AUD. This hy-
pothesis is further driven by findings that after months of alcohol
abstinence, D2R availability is not recovered in individuals with
AUD (Volkow et al., 2002). In animal models, the overexpression
of striatal D2Rs was shown to reduce ethanol self-administration
and preference (Thanos et al., 2001), but in a more recent study,
D2R overexpression in the ventral striatum did not produce the
same phenotype (Gallo et al., 2015).
Global Drd2 knockout mice with a ubiquitous deletion of D2Rs
show enhanced ethanol-induced simulation when tested in a
familiar environment and decreased sedation in a novel environ-
ment (Palmer et al., 2003; Phillips et al., 1998), suggesting a role
for these receptors. However, Drd2 knockout mice have also
been shown to self-administer less ethanol compared to controls
(Risinger et al., 2000). While it is tempting to conclude that these
data indicate that D2Rs are unrelated to the reinforcing effects ofCell Reports 29, 1147–1163, October 29, 2019 1147
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Inbred Mice Show Ethanol Stimulatory and Sedative Effects with Individual Variability Correlating with Intoxication
(A) Left, sample traces of locomotor activity for 5min following injection of saline (black) or 2 g/kg ethanol (green) in Drd2loxP/loxPmice (n = 23). Right, time course of
locomotor activity following saline (black) or 2 g/kg ethanol (green) in Drd2loxP/loxP mice (2-way repeated-measures [RMs] ANOVA: F5,110 = 4.3, p < 0.01). Shaded
box highlights ethanol stimulation during first 5 min. **p < 0.01, Bonferroni’s multiple comparison.
(B) Dose-dependent ethanol stimulation plotted as locomotion 5 min after ethanol administration (n = 23; F3.59,78.89 = 2.8; *p < 0.05).
(C) Frequency histogram of individual mouse responses to 2 g/kg ethanol during first 5 min, presented as percentage of activity after saline (top x axis) and as
stimulation score (bottom x axis).
(D) Schematic illustrating the loss of righting reflex (LORR) task.
(E and F) No significant correlation between stimulatory scores and latency to LORR (E) (n = 17; Pearson’s r = 0.01, p > 0.05), while an inverse trend is seen
between stimulation scores and LORR duration in Drd2loxP/loxP mice (F) (n = 17; Pearson’s r = 0.46, p = 0.06).
(G) Frequency histogram of mouse LORR duration illustrates the range of individual variability.
(H) Top, outline of experimental protocol showing sequence of tests and days (ticks) in which tail blood samples (red drop) were taken and processed for BEC.
Bottom, average ethanol intake (purple symbols) of individual mouse data (gray lines; n = 34).
(legend continued on next page)
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alcohol, the Drd2 knockoutmice also self-administered less food
and sucrose, indicating a more generalized reward deficit.
The reason for these confounding data is likely that D2Rs are
located on a variety of cell types throughout the striatum,
including GABAergic medium spiny projection neurons, cholin-
ergic interneurons, and dopaminergic terminals emanating
from midbrain dopamine (DA) neurons, where they are known
to have differential effects. Fully understanding the role of
D2Rs in alcohol-related circuitry demands the use of cell-type-
specific analysis, rather than global knockouts. This allows us
to identify which populations of striatal D2Rs are affected in in-
stances of alcohol abuse and contribute to the abuse-vulnerable
phenotype.
In the present study, we demonstrate a link between striatal
D2Rs and the stimulant effects of ethanol, pointing to a critical
role of D2Rs expressed on medium spiny neurons (MSNs) in
generating the vulnerability and offer direct evidence for a mech-
anism driving higher ethanol preference and escalation of
drinking.
We validate the use of mouse models in the study of the stim-
ulant effects of alcohol. We then show that pre-existing low
levels of striatal D2Rs in select cell types are sufficient in modu-
lating ethanol stimulation and alcohol drinking behavior. The se-
lective loss of D2Rs on medium spiny neurons left mice with a
higher sensitivity to ethanol stimulation and resistance to the
sedative effects. These mice also showed a higher ethanol pref-
erence and escalation of drinking. We further show that the
activation of D1Rs in the dorsal striatum is required for ethanol
stimulation and promotes ethanol preference. The present study
then builds on our previous research, showing that low levels of
D2Rs in medium spiny neurons are associated with an upregula-
tion in DA D1 receptor (D1R) functioning in the direct-pathway
medium spiny neurons. As such, here, we propose that the
loss of striatal medium spiny neuron D2Rs triggers the hypersen-
sitivity of striatal D1Rs, which in turn drives the stimulatory ef-
fects of ethanol and compulsive-like intake. This study offers a
mechanistic understanding of how low levels of D2Rs confer
vulnerability to alcohol abuse.
RESULTS
Assessment of Ethanol Stimulatory andSedative Effects
in Mice of C57BL/6J Background
We first characterized and validated the use of locomotor mea-
surements in assessing the biphasic ethanol-induced stimula-
tory and sedative effects in Drd2loxP/loxP mice. These mice
have loxP sites in the Drd2 gene, making them amenable to
Cre-induced deletion of the start codon of Drd2 mRNA, but are
otherwise identical to C57BL/6J wild-type mice (Bello et al.,
2011). Male and female Drd2loxP/loxP mice were administered
varying doses of ethanol (0.5–3 g/kg, intraperitoneally [i.p.]) using
a Latin square design, and locomotion was quantified using(I and J) The mean individual ethanol intake (I) and BEC (J) achieved during DID s
(n = 12; Pearson’s r = 0.6 and r = 0.62, respectively; p < 0.05).
(K and L) The mean individual ethanol intake showed no correlation with LORR du
mean BEC achieved during DID (L) (Pearson’s r = 0.30, p > 0.05).
All of the symbols with error bars are means ± SEMs; symbols without error barsinfrared beam breaks. Consistent with the literature, ethanol pro-
duced transient, dose-dependent stimulatory effects that peak
at 2 g/kg (Figure 1A, p < 0.05; Figure 1B, p < 0.01 for 2 g/kg
ethanol) (Cohen et al., 1997; Liljequist et al., 1981; Read et al.,
1960). There was a great deal of individual variability in ethanol
stimulation, despite the fact that thesemice are an inbred, genet-
ically homogeneous strain (Figure 1C). While on average, the
mice showed increased locomotion when administered ethanol
compared to saline, some mice showed larger effects than
others, and females showed higher stimulation (Figures S1A
and S1B, p < 0.05) and larger individual variability compared to
males (SD: 191 versus 93 for females and males, respectively).
These sex differences are consistent with the literature (Crabbe
et al., 1987).
The transient ethanol-induced stimulation was followed by the
onset of the sedative effects of ethanol that were longer lasting
and maximal at higher doses (Figures S2A and S2B). The seda-
tive effects of ethanol also showed significant individual vari-
ability (Figure S2C); however, no statistical difference was seen
between males and females following 2.5 or 3 g/kg ethanol (Fig-
ures S1C and S1D).
Stimulatory and sedative scores were calculated for each
mouse by normalizing locomotion following 2 g/kg ethanol to
the value following saline and subtracting 100, so no change
from saline corresponded to a zero score (Figures S2D and
S2E). We identified an inverse correlation between the transient
stimulatory score and the subsequent sedative score among in-
dividual animals (Figure S2F, p < 0.05), which parallels what is
seen in humans (Martin et al., 1993). However, because the
two measurements rely on the same locomotor task and are
therefore not independent and dissociable, we considered it
important to obtain an independent measurement of ethanol-
induced sedation.
The loss of righting reflex (LORR) test was carried out to further
examine sedation. Control mice were administered a high, anes-
thetic dose of ethanol (3.5 g/kg, i.p.), and the latency to lose and
regain the ability to right from a supine position was recorded
(Figure 1D). The latency to LORR was 4.5 ± 0.8 min, and the
time to regain the righting reflex was 33 ± 3 min. We then looked
at the correlation between parameters of the LORR task and the
stimulatory response to ethanol. While the latency to lose the
righting reflex was not correlated with the stimulatory response
to ethanol (Figure 1E, p > 0.05), the time to regain the reflex
showed a trend of negative correlation with ethanol-induced
locomotion (Figure 1F, p = 0.06). This is further indicative of an
inverse correlation between ethanol-induced sedation and stim-
ulation in rodents, as assessed by two independent measures.
Again, individual variation was observed in this congenic mouse
population (Figure 1G). When examining sex differences, there
was no difference in the latency to LORR in male and female
mice (Figure S1E, p > 0.05). However, the LORR duration was
longer and individual variability was larger in males comparedhow a significant positive correlation with the stimulation score of each mouse
ration (K) (n = 22; Pearson’s r =0.42, p% 0.05) but an inverse correlation with
represent data from individual animals.
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to females, indicating that female mice are more resistant
to ethanol sedation (Figure S1F; SD males: 11.6 versus SD fe-
males: 5.8).
Individual Variability in Ethanol Stimulation and
Sedation Has Predictive Value on Voluntary Ethanol
Intake
To further test whether individual variability in stimulatory
response to ethanol had predictive value over ethanol consump-
tion, as suggested in humans, we examined the relation between
stimulatory and sedative responses and ethanol consumption.
Two separate groups of mice were tested for either ethanol
stimulation (2 g/kg ethanol) or LORR (3.5 g/kg ethanol). All of
the mice were then given access to 20% ethanol solution in
the home cage for 4 h/day. This 3-week-long paradigm of volun-
tarily drinking is a modified version of the ‘‘drinking in the dark’’
(DID) paradigm (Figure 1H, upper panel). Tail blood samples
were taken twice per week and analyzed for blood ethanol con-
centration (BEC). Again, individual variability was noticed during
DID (Figure 1H, lower panel). We found that the degree of
ethanol-induced stimulation for each mouse was positively
correlated with voluntary ethanol intake and BECs (Figures 1I
and 1J, p < 0.05 for both). Ethanol-induced sedation, on the con-
trary, showed a negative correlation with BECs (p = 0.05) and no
association with voluntary intake (Figures 1K and 1L, p = 0.17).
Consistent with the enhanced stimulation, female mice
consumed more ethanol than did males during DID (Figure S1G,
p < 0.05). While not significant, there was a trend toward higher
BECs following voluntary drinking in females (Figure S1H, p >
0.05). These data are in agreement with previous reports
showing higher ethanol intake in females on operant and non-
operant paradigms (Blegen et al., 2018; Yoneyama et al., 2008).
In the present experiment, all of the mice were exposed to an
acute dose of ethanol (either in stimulatory testing or LORR),
which would have subsequent effects on drinking. However,
despite the fact that all of the mice were similarly exposed, indi-
vidual variability endured.
Taken together, the findings from the mousemodels align with
the clinical literature, showing that in mice, similar to humans, in-
dividual variability in the stimulant and sedative effects of ethanol
has predictive value for voluntary intoxication. These findings
validate the use of these behavioral approaches to study the
mechanisms underlying AUD. Finally, the fact that significant in-
dividual variability in ethanol response persists in a congenic
mouse strain reinforces the idea that the phenotypic variation
is the result of gene-environment interactions and not genes
alone.
Mouse Models of Cell-Specific Ablation of D2Rs in the
Striatum
Three conditional mutant mouse lines with deletion of D2Rs in
specific neuronal types were generated and used to test the
link between low striatal D2R availability and ethanol behaviors.
D2Rs were selectively removed from striatal GABAergic medium
spiny neurons that form the indirect projection pathway (iMSNs),
cholinergic interneurons (CINs), or the axonal projections origi-
nating from midbrain DA neurons (Figure 2A). To selectively re-
move the subpopulations of D2Rs, conditional mice for the1150 Cell Reports 29, 1147–1163, October 29, 2019Drd2 gene (Drd2loxP/loxP) were crossed with mice expressing
Cre under different promoters to selectively target iMSNs,
CINs, and DA neurons (adenosine 2a receptors [Adora2a],
cholinergic acetyl transferase [ChAT], and DA transporter
[DAT], respectively; Figure 2B) (Bello et al., 2011; Lemos et al.,
2016). Striatal D2R availability was assessed using radioligand
binding of the D2R-like antagonist [3H]-methylspiperone in ho-
mogenized striatal tissue. A robust decrease in D2R binding
(54% ± 2%) was found in iMSN-Drd2KO (knockout) mice
compared to littermate controls (Figures 2C–2G, p < 0.05). This
is anatomically consistent in that 95% of striatal neurons are me-
dium spiny neurons, half of which expressD2Rs (Gerfen and Sur-
meier, 2011; Tepper et al., 2007). Auto-Drd2KO (mice lacking
D2Rs in DA neurons) and Cin-Drd2KO (mice lacking D2Rs on
cholinergic interneurons) showed moderate decreases in striatal
D2R binding (21% ± 11% and 10% ± 12%, respectively), which
reflect their portions of the total striatal D2R population. Low-ex-
pressing D3R or D4R does not significantly contribute to striatal
D2-like radioligand binding, as D3R (Accili et al., 1996; Xu et al.,
1997) or D4R (Rubinstein et al., 1997) global knockout mice do
not show a decrease in D2R binding, and binding is completely
ablated in global D2R-deficient animals (Baik et al., 1995).
Targeted Deletion of D2Rs on MSNs Enhances Ethanol-
Induced Stimulation
All threemouse lines were tested for ethanol-induced stimulation
and sedation in comparison to littermate controls. No differences
were found among the littermate controls, so all of the control
data were pooled. iMSN-Drd2KO mice show an upward shift in
the dose-specific stimulatory effects of ethanol. They also
display a larger increase in locomotion normalized to baseline
for all doses compared to control littermates, Cin-Drd2KO, and
auto-Drd2KO mice (Figure 3A, corresponding raw data in Fig-
ure S3E, p < 0.05). Ethanol-induced stimulation was longer last-
ing in iMSN-Drd2KO mice compared to littermate controls. In
agreement with our previous report, iMSN-Drd2KO mice are hy-
polocomotive at baseline compared to littermate controls and
the other genotypes (Figure S3) (Lemos et al., 2016). As such,
ethanol at 2 g/kg appears to restore locomotion to the levels
seen in littermate controls (Figures 3B and S3E); however, loco-
motion is visually uncoordinated and impaired (see Video S1)
and mice are intoxicated, as shown by similar levels of blood
ethanol concentration (Figure 3C). Ethanol stimulation in Cin-
Drd2KO and auto-Drd2KO mice was indistinguishable from
littermate controls. At high ethanol doses (2 or 3 g/kg), littermate
controls, Cin-Drd2KO, and auto-Drd2KO mice show ethanol-
induced sedation, while iMSN-Drd2KO mice show a profound
and persistent stimulatory effect (Figures S3C, S3D, and S3J).
Experiments were counterbalanced for sex, so observed ge-
notype differences are not likely driven by sex differences. While
underpowered, the sex-sorted data presented in Figures S4A
and S4B show that both male and female iMSN-Drd2KO mice
have a 3-fold increase in locomotion in response to ethanol,
which is higher than the 50% increase seen in controls (Figures
S1B and S4B). Similar to the findings in Figure S1G, female
iMSN-Drd2KO mice show a higher daily intake of ethanol on
DID compared to males (Figure S4C). While some sex differ-
ences seen in the control mice are similarly preserved in the
0.0 0.5 1.0 1.5 2.0 2.5
0
300
600
900
[3H]- Methylspiperone (nM)
S
pe
ci
fic
 b
in
di
ng
 
[3
H
]-
M
et
hy
ls
pi
pe
ro
ne
 (f
m
ol
/m
g)
iMSN-Drd2KO
Drd2
loxP/loxP
auto-Drd2KO
Drd2
loxP/loxP
A
C D E
F G
[3H]- Methylspiperone (nM)
S
pe
ci
fic
 b
in
di
ng
 
[3
H
]-
M
et
hy
ls
pi
pe
ro
ne
 (f
m
ol
/m
g)
S
pe
ci
fic
 b
in
di
ng
 
[3
H
]-
M
et
hy
ls
pi
pe
ro
ne
 (f
m
ol
/m
g)
Drd
2
lox
P/lo
xP
iMS
N-D
rd2
KO
aut
o-D
rd2
KO
Cin
-Dr
d2K
O
Drd
2
lox
P/lo
xP
iMS
N-D
rd2
KO
aut
o-D
rd2
KO
Cin
-Dr
d2K
O
Cin-Drd2KO
Drd2
loxP/loxP
Affinity
0
300
600
900
K
d 
(n
M
)
[3
H
]-
M
et
hy
ls
pi
pe
ro
ne
 b
in
di
ng
[3
H
]-
M
et
hy
ls
pi
pe
ro
ne
 b
in
di
ng
0.0 0.5 1.0 1.5 2.0 2.5 3.0
0
300
600
900
[3H]- Methylspiperone (nM)
0.0 0.5 1.0 1.5 2.0 2.5
Drd2
loxP/loxP
Adora2acre
DAT
ChAT
IREScre
IREScre
iMSN-Drd2KO
auto-Drd2KO
Cin-Drd2KO
Targets D2Rs on iMSNs
Targets D2 autoreceptors 
on dopamine neurons
Targets D2Rs on 
cholinergic interneurons 
B
Breeding schemes
0
500
1000
1500
B
m
ax
(f
m
ol
/m
g 
pr
ot
ei
n)
Total Specific Binding 
**
0.0
0.5
1.0
1.5
Figure 2. Cell-Specific Deletion of Drd2 Gene Causes Selective Reduction of D2R Binding Availability
(A) Diagram illustrating the main neuronal populations, with D2Rs localized in the striatum.
(B) Breeding scheme for the cell-specific knockout of Drd2.
(C–E) Representative saturation binding curves for [3H]-methylspiperone in striatal samples from iMSN-Drd2KO (C), auto-Drd2KO (D), and Cin-Drd2KO (E) and
respective littermate controls. Lines represent fit from non-linear regression analyses.
(F and G) Total specific binding, Bmax, (F) and binding affinity, dissociation constant (G). **p < 0.01, Dunnett’s multiple comparison after 1-way ANOVA: F5,31 =
2.6, p < 0.05 for total specific binding. No difference was seen in Kd across genotypes (F5,31 = 0.13, p > 0.05; n = 4–5/group, 3 replicates).
All of the symbols with error bars are means ± SEMs; symbols without error bars represent data from individual animals.iMSN-Drd2KO mice, these effects do not appear to be driving
the observed genotype differences.
Of note, on the locomotor stimulatory task, auto-Drd2KOmice
were more sensitive to the sedative properties of ethanol, with
mice showing lower locomotor activity 1 h after 2 g/kg ethanol,
compared to littermate controls (Figure 3D). Across genotypes,
there were no differences in BECs measured 5 or 60 min post-
ethanol administration (p > 0.05 for both time points), indicating
that the differences in ethanol-induced stimulation and sedation
are not likely due to differences in drug metabolism (Figures 3C
and 3F). Furthermore, we tested whether Cre expression in me-
dium spiny neurons could account for the hypersensitive ethanol
stimulation seen in iMSN-Drd2KO mice. Adora2a-Cre+ miceshowed locomotor responses that were indistinguishable from
Cre littermate controls when given 3 g/kg ethanol (Figures
S4D and S4E, p > 0.05 for both). These results indicate that
the phenotypic difference seen in iMSN-Drd2KO mice are not
merely due to the expression of Cre.
Selective Loss of D2Rs on Medium Spiny Neurons
Creates Resilience to Ethanol Sedation
iMSN-Drd2KO mice were also resilient to the sedative effects of
ethanol on the LORR task. Only 50% of iMSN-Drd2KO mice lost
the righting reflex after 3.5 g/kg ethanol, while >90% of auto-
Drd2KO, Cin-Drd2Kos, and littermate controls did (Figures 3G
and 3H, p < 0.05). A similar mean latency to loss and durationCell Reports 29, 1147–1163, October 29, 2019 1151
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Figure 3. iMSN-Drd2KO Mice Display High Ethanol Stimulation and Resiliency to Ethanol Sedation
(A and D) Dose-response curve of ethanol-induced locomotion for iMSN-Drd2KO (red), auto-Drd2KO (blue), Cin-Drd2KO (green), and littermate control (black)
mice 5min following ethanol administration (A); n = 12–23/group; 2-way RMs ANOVA ethanol dose3 genotype: F15,250 = 2.69, p < 0.001; ***p < 0.001. Main effect
(legend continued on next page)
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of the effect were seen across genotypes among the mice that
lost their righting reflex (Figure 3G). Again, there were no differ-
ences in BECs across genotypes at the time of righting regain
(Figure 3J). Furthermore, BECs were no different in iMSN-
Drd2KO mice that lost their righting reflex and those that did
not (Figure 3J, inset). Consistent with our previous finding, these
results support the interpretation that iMSN-Drd2KO mice are
less sensitive to the sedative properties of ethanol, despite
achieving similar BECs.
Higher Preference for Ethanol Consumption in Mice
with Enhanced Ethanol Stimulation
Mice were run on the ethanol locomotor test (2 g/kg ethanol) and
then assessed in a 2-bottle choice test, where theywere given ad
libitum access to both ethanol and water for 3 days (Figure 4A).
Preference was determined as the ratio of ethanol consumed to
total fluid intake. Because CIN-Drd2KO mice showed no differ-
ential response to ethanol stimulation or sedation, they were
not tested further. iMSN-Drd2KO mice showed a higher ethanol
preference compared to littermate controls and auto-Drd2KO
mice (Figure 4B, p < 0.01). Across iMSN-Drd2KOmice and litter-
mate controls, ethanol preference scores were positively corre-
lated with ethanol-induced stimulation (Figure 4C, p < 0.01). No
significant differences were found in overall ethanol consump-
tion or fluid intake across genotypes (Figure 4D). Furthermore,
when ethanol intake was assessed using the DID paradigm, all
of the genotypes consumed similar amounts of ethanol and
showed no differences in BECs (Figures 4E and 4F). Thus, while
micewith lowD2Rs inmedium spiny neurons show a higher pref-
erence for ethanol, they do not consume more ethanol under the
parameters tested here.
The higher ethanol preference scores observed in iMSN-
Drd2KO mice compared to littermate controls were selective
for ethanol, as these mice did not show a higher preference for
1% sucrose solution (Figure 4G; iMSN-Drd2KO mice: 87% ±
3% preference, Drd2loxP/loxP mice: 95% ± 1% preference,
auto-Drd2KO mice: 91% ± 3%).
Mice with Low Striatal D2Rs Show More Escalation of
Ethanol Intake in an Operant Paradigm
iMSN-Drd2KO mice, auto-Drd2KO mice, and littermate controls
were tested in an operant paradigm for ethanol self-administra-
tion. Mice were pre-exposed to 20% ethanol solution using the
DID paradigm (data previously described; Figure 4E). After
3 weeks, mice were given access to the same solution in an op-
erant chamber with 2 levers (active and inactive) and a retract-of dose: F5,250 = 8.15, p < 0.0001.Main effect of genotype: F3,50 = 13.8, p < 0.0001,
2.27, p < 0.001; ***p < 0.001. Main effect of genotype: F3,50 = 4.06, p < 0.05.
(B and E) Representative traces of locomotor activity in Drd2loxP/loxP (black) and i
injection (left) or 2 g/kg ethanol (right).
(C and F) BEC measured 5 min (C); n = 8–12/group; 2-way RMs ANOVA ethano
ethanol dose 3 genotype: F9,96 = 0.97, p > 0.05 following injection of 0, 1, 2, and
(G and I) Time to LORR (G) (n = 7–10/group; 1-way ANOVA: F2,32 = 0.25, p > 0.05) a
dotted line (G) indicate mice that did not lose the righting reflex by the 90-min cu
(H) Percentage of mice from each genotype that lost the righting reflex for each
(J) BEC measured at regaining righting reflex or at the cutoff time (1-way ANOVA
righting reflex (LORR) compared to those that did not (no LORR; independent sa
All of the symbols with error bars are means ± SEMs; symbols without error barsable sipper tube (Figure 5A). The first 3 training sessions were
6 h long and the remainder of the training sessions were 2 h.
No sucrose fading was used during operant training. No differ-
ences were found across the genotypes in the rate of response
for active and inactive levers during the 2-h training sessions
(Figures S5A and S5B).
Ethanol consumption was quantified in three ways: intake (vol-
ume consumed per body weight), rate of sipper licking, and
BECs at the end of weeks 2 and 3. When compared across ge-
notypes, iMSN-Drd2KO mice consumed less ethanol during the
first 2-h training sessions, but by the end of the third week of
training, the overall ethanol intake was similar for all of the geno-
types (Figures 5B and 5C; Drd2loxP/loxP: 2.0 ± 0.2 g/kg/2 h, auto-
Drd2KO: 1.5 ± 0.6 g/kg/2 h, and iMSN-Drd2KO: 1.6 ± 0.6
g/kg/2 h; p > 0.05). Licking behavior mirrored ethanol intake for
iMSN-Drd2KO mice (Figure 5D). Thus, iMSN-Drd2KO mice
show an escalating pattern of drinking behavior, which has
been suggested to be a hallmark of addiction liability (Edwards
and Koob, 2013). iMSN-Drd2KO mice did not drink more during
the time frame tested here; however, if this escalation pattern
were to continue, then higher levels of intake could be predicted
over time.
Unbiased unsupervised cluster analysis of daily intake on self-
administration for all of the mice allowed us to discriminate three
patterns of ethanol intake: stable drinkers, escalators, and non-
drinkers (Figure S6A). Non-drinkers and stable drinkers showed
consistent intake patterns throughout training (Figures S6B–
S6D; early sessions [4 and 5]: 1.5 ± 0.3 g/kg/day, late sessions
[17 and 18]: 1.5 ± 0.2 g/kg/day), but non-drinkers consumed
very little ethanol (early sessions: 0.15 ± 0.08 g/kg/day, late ses-
sions: 0.04 ± 0.02 g/kg/day). Escalators, however, started by
consuming low amounts of ethanol in the beginning (0.25 ±
0.16 g/kg/day) and increased their intake over the course of
training (2.5 ± 0.4 g/kg/day; Figure S6D). iMSN-Drd2KO mice
were more likely to be classified as escalators compared to con-
trol and auto-Drd2KO mice (Figures 5E and S6E). The escalation
of intake and licking was also apparent during the relapse test, in
which access to ethanol was reintroduced after 40 days of absti-
nence. iMSN-Drd2KO mice showed a 5-fold increase in intake
during the 6-h relapse sessions compared to the 6-h training
sessions (490% ± 89%), while auto-Drd2KO showed a 3-fold in-
crease (312% ± 78%) and controls barely double intake (183% ±
35%; Figure 5F). The rate of licking was also higher during
relapse selectively for iMSN-drd2KO (Figures S5C and S5D).
When mice were tested for alcohol seeking in the absence of
ethanol, iMSN-Drd2KO mice showed a lower rate of lickingand 5–60min following ethanol injection (D); ethanol dose3 genotype: F15,250 =
MSN-Drd2KO (red) mice during first 5 min (B) and 5–60 min (E) following saline
l dose 3 genotype: F9,100 = 0.89, p > 0.05 and 60 min (F); 2-way RMs ANOVA
3 g/kg ethanol.
nd duration of LORR (I); 1-way ANOVA: F2,32 = 2.42, p > 0.05. Data points above
toff time.
genotype.
: F3,58 = 1.19, p > 0.05). Inset shows BEC for iMSN-Drd2KO mice that lost the
mple t test: t(8) = 0.1, p > 0.05).
represent data from individual animals.
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Figure 4. Higher Preference for Ethanol Drinking in Mice Lacking D2Rs in iMSNs
(A) Schematic of experimental design; mice were tested for ethanol-induced locomotion followed by 2-bottle ethanol preference test and 3 weeks of DID. Blood
sampling for BEC indicated by red drop. Shaded areas indicate days of experimental testing.
(B) Average ethanol preference scores on 2-bottle choice (n = 12–23/group; 1-way ANOVA: F2,49 = 5.87, p < 0.01) followed by Tukey tests; **p < 0.01.
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(D) No differences in total daily fluid intake during 2-bottle choice test (1-way ANOVA: F2,51 = 0.19, p > 0.05).
(E) Average daily ethanol intake during DID (n = 12–23/group; 2-way RMs ANOVA time 3 genotype: F2,28 = 0.7, p > 0.05).
(F) Weekly mean BECs achieved during DID (2-way RMs ANOVA time 3 genotype, F1,2 = 8.44, p > 0.05).
(G) Sucrose preference scores (n = 9–11/group; 1-way ANOVA: F2,37 = 4.25 followed by Tukey tests; *p < 0.05).
All of the symbols with error bars are means ± SEMs; symbols without error bars represent data from individual animals.than baseline, suggesting that the high rate of licking during
relapse was driven by ethanol availability and not just the pres-
ence of conditioned cues, such as sipper presentation (Figures
S5E and S5F).
Resistance to Quinine Adulteration in Mice with Low
Striatal D2Rs
Ethanol drinking despite adverse consequences is a hallmark of
AUD. Using the operant paradigm, we tested whether the adul-
teration of ethanol with an unpleasant bitter tastant, quinine,
would deter mice from drinking or seeking ethanol. As antici-
pated, littermate controls showed a concentration-dependent1154 Cell Reports 29, 1147–1163, October 29, 2019decrease in ethanol intake during adulteration sessions
(0.5 mM: 73% ± 8% reduction and 1 mM: 54% ± 11% reduction)
as did mice lacking D2Rs in DA neurons (0.5 mM: 47% ± 14%
and 1 mM: 28% ± 11%). iMSN-Drd2KO mice were undeterred
by quinine adulteration and showed no significant decrease in
ethanol intake (Figure 5G). When iMSN-Drd2KO mice and litter-
mate controls were given access to water with 0.5 or 1 mM qui-
nine, all of the mice decreased their intake of the adulterated
water (Figure 5H), indicating that all of the mice are able to taste
the quinine and do not prefer it. Furthermore, it is unlikely that
these results are due to generalized taste impairment, because
iMSN-Drd2KO mice show a preference for sucrose over water
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Figure 5. More Escalation of Ethanol Drinking and Higher Resistance to Quinine Adulteration in Mice Lacking iMSN D2Rs during Operant
Self-Administration Task
(A) Schematic of experimental design for operant ethanol self-administration (SA). Following 3 weeks of DID, mice were trained to self-administer ethanol (FR1,
FR3). After training, mice were tested for ethanol adulteration with quinine, ethanol seeking after abstinence, and ethanol relapse (n = 6–13/group).
(B) Ethanol intake during the 2-h SA sessions for iMSN-Drd2KO (red), auto-Drd2KO (blue), and littermate control (black) mice.
(C) Ethanol intake during early training (open bars/round symbols) and later training (filled bars/square symbols). The connected symbols represent data from
individual mice.
(legend continued on next page)
Cell Reports 29, 1147–1163, October 29, 2019 1155
(Figure 4G). These data show that while iMSN-Drd2KO mice do
not drink more ethanol overall, they show qualitative changes in
drinking patterns, including escalation of intake and insensitivity
to aversive pairing.
Ethanol Activates D1R-Mediated Intracellular Signaling
in the Striatum
We used pharmacological tools to further understand the mech-
anism by which low expression of medium spiny neuron D2Rs
causes enhanced ethanol stimulation and preference. There is
substantial evidence that chronic ethanol drives the activation
of D1R signaling in the dorsomedial striatum (Wang et al., 2012,
2015). We hypothesized that acute ethanol exposure would also
activate D1R activity and lead to protein kinase A (PKA)-depen-
dent phosphorylation of downstream targets, such as pGLUA1
at serine-845. Furthermore, we predicted that iMSN-Drd2KO
mice would display enhanced activation of targets downstream
of D1R based on our recent findings that mice lacking medium
spiny neuron D2Rs display D1R hypersensitivity at both the
cellular/signaling and behavioral levels (Dobbs et al., 2019).
Mice were administered either saline, the D1-like agonist SKF-
81297 (5 mg/kg), or ethanol (2 g/kg). The dorsomedial striatum
(DMS) was processed for quantitative protein analysis (Figures
6A–6C). SKF-81297 enhanced normalized pGluA1 levels in the
DMS of both genotypes, which is consistent with previous find-
ings. At the time point tested, following 2 g/kg ethanol, a small,
statistically insignificant increase in pGluA1 levels was seen in
Drd2loxP/loxP mice compared to when saline was administered
(Figures 6D and 6E). However, in iMSN-Drd2KO mice, acute
ethanol robustly increased pGluA1 to levels similar to those
seen following the D1-like receptor agonist (Figures 6D and
6E). When normalized to total GluA1 levels, the effect of ethanol
in iMSN-Drd2KO mice on DMS pGluA1 levels was further pro-
nounced (Figure S7A). No changes were observed in total pro-
tein levels for GluA1 (Figure 6F) and glyceraldehyde 3-phosphate
dehydrogenase GAPDH (Figure S7B) in the DMS across the ge-
notypes and treatments.
DA D1R Activation Is Required for Ethanol-Induced
Stimulation
The protein analysis data show that ethanol exposure mimics
exposure to a D1-like agonist in mice lacking D2Rs on medium
spiny neurons. Previous work suggests a positive correlation be-
tween ethanol-induced stimulation and the sensitivity of D1Rs in
the striatal pathway (Abrahao et al., 2014). We speculated that
the D1R hypersensitivity in iMSN-Drd2KO mice could be the un-
derlying mechanism driving the enhanced ethanol stimulation
and ethanol preference.(D) Rate of sipper licking during training sessions for iMSN-Drd2KO (red), auto-D
(E) Percentage of mice from each genotype displaying escalating drinking patter
(F) Ethanol intake during first 3 training sessions (open bars/round symbols) an
represent data from individual mice (paired t test t(5) = 3.25; *p < 0.05 for iMSN-
(G) Ethanol intake during quinine adulteration sessions (2-way ANOVA genotype3
0.001).
(H) Two-bottle choice test for water and water adulterated with quinine. No dif
genotype: F1,51 = 0.83, p > 0.05) for iMSN-Drd2KO (red) and littermate controls (
All of the symbols with error bars are means ± SEMs; symbols without error bars
1156 Cell Reports 29, 1147–1163, October 29, 2019We directly examined the effect of a D1-like receptor antago-
nist, SCH-23390, on ethanol-induced stimulation. Pretreatment
with SCH-23390 dose-dependently blocked ethanol-induced
locomotion in iMSN-Drd2KO mice and littermate controls (Fig-
ure 6G). The inhibition was significant with the pretreatment of
0.075 mg/kg SCH-23390 for both genotypes (Figure 6H; 71%
± 9% inhibition for Drd2loxP/loxP; 56% ± 15% inhibition in
iMSN-Drd2KO) and was even larger at 0.3 mg/kg SCH-23390.
SCH-23390 alone also decreased locomotion in littermate con-
trols and iMSN-Drd2KO mice (Figures 6I, S7C, and S7D). Mice
lacking D2Rs on medium spiny neurons were less sensitive to
the acute effects of the D1-like receptor antagonist. In littermate
controls, 0.075 g/kg SCH-23390 alone produced a 54% ± 12%
suppression of locomotion compared to saline, but the same
dose had no effect on locomotion in iMSN-Drd2KO mice (Fig-
ure 6I). A larger dose of SCH-23390 (0.3 g/kg) alone suppressed
locomotion in both controls and iMSN-Drd2KO mice (Figure 6I),
indicating a rightward shift in the dose response.
When measuring locomotion at later time points after ethanol
administration, pretreatment with the D1-like receptor antago-
nist suppressed the long-lasting ethanol-induced stimulatory ef-
fects in iMSN-Drd2KO mice (Figures S7E and S7F). In summary,
D1R activation is required for the stimulant but not the sedative
effects of ethanol in both control mice and mice lacking medium
spiny neuron D2Rs.
D1Rs Expressed in the Dorsal Striatum Are Required for
Ethanol-Induced Stimulation
To determine the regional specificity of the role of D1R in medi-
ating the stimulant effects of ethanol, we selectively knocked
down the Drd1 gene in the ventral or the dorsal subregions of
the striatum. A viral vector expressing Cre recombinase and
GFP, or a control vector expressing only GFP, was injected intra-
cranially in these areas in transgenic mice homozygous for the
conditional Drd1 allele (Drd1loxP/loxP; Figure 7A; Sarin˜ana et al.,
2014). The degree of Drd1 knockdown was assessed using
qPCR analysis of tissue. Targeting the Cre vector to the dorsal
subregion resulted in a 54%± 9% reduction in Drd1mRNA levels
selectively in the dorsal striatum 8 weeks after viral vector injec-
tion (Figure 7B). It did not affect Drd1 mRNA levels in the ventral
striatum compared to littermate mice that received the control
GFP vector. When targeting the ventral striatum, Drd1 mRNA
levels were reduced by 56% ± 4% in the ventral region (Fig-
ure 7B), and a modest decrease (16% ± 4%) was noted in the
dorsal striatum after 8 weeks.
The degree of functional loss of D1R activation was assessed
by measuring the locomotor response to the D1-like receptor
agonist SKF-81297 (7.5 mg/kg) 6 weeks after surgery (data notrd2KO (blue), and littermate control (black) mice (n = 18/group).
n.
d the relapse session (filled bars/square symbols). The connected symbols
Drd2KO).
dose: F4,44 = 3.01, p < 0.001; followed byDunnett’smultiple comparison; ***p <
ferences in preference scores (n = 14/group; 2-way ANOVA quinine dose 3
black).
represent data from individual animals.
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Figure 6. Ethanol-Induced PKA-Dependent Signaling and D1R Activation Are Enhanced in Striatum of iMSN-Drd2KOMice, and Blockade of
D1R Attenuates Ethanol Stimulation
(A) Schematic describing experimental procedure: iMSN-Drd2KO and littermate control mice were administered saline, SKF-81297, or ethanol. The dorsomedial
striatum was dissected for protein level analysis (n = 5–6/group).
(B and C) Representative chemiluminescence traces for phosphorylated GluA1 (pGluA1) and control protein GAPDH in littermate (B) and iMSN-Drd2KO (C) mice
following saline (black), SKF-81297 (dash), or ethanol (gray).
(D and F) Protein level quantification as pGluA1 and GAPDH ratio (D) and total GluA1 over GAPDH ratio (F) after saline (open), SKF-81297 (shaded), and ethanol
(solid) for control littermate (black) and iMSN-Drd2KOmice (red). (D) pGLUA1 ratio 1-way ANOVA for control littermatemice: F2,13 = 4.45 and iMSN-Drd2KOmice:
F2,14 = 3.89, followed by Tukey multiple comparison tests; *p < 0.05. For total GLUA1 ratio (F), 1-way ANOVA for littermate mice: F2,13 = 0.35 and iMSN-Drd2KO:
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(E) pGluA1 protein levels after SKF-81297 (shaded) and ethanol (solid) expressed as percentage of saline in littermate (black) and iMSN-Drd2KO (red) mice. *p <
0.05, one-sample t test examining divergence from saline baseline.
(legend continued on next page)
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shown). In the case of the ventral striatum-targeted deletion, the
agonist induced robust locomotor activation to a similar degree
in both GFP-expressing control mice and Cre-expressing mice
(522% ± 64% and 657% ± 90% increase over saline injection
for control GFP and Cre, respectively; saline versus SKF; F1,9 =
126.1, p < 0.01; no effect of virus group). However, mice with tar-
geted knockdown of Drd1 in the dorsal striatum showed >50%
reduction in SKF 81297-induced locomotion compared to GFP
controls (1,020% ± 124% and 489% ± 54% increase over saline
injection for control GFP-expressing and Cre-expressing mice;
F1,14 = 16.3, p < 0.01). Baseline locomotion was not altered by
these manipulations (1,303 ± 673 and 1,616 ± 593 counts per
hour for Cre and GFP-control vector, respectively; t(24) = 0.35,
p > 0.05). Thus, this combined viral and genetic approach can
effectively reduce Drd1 mRNA in select striatal subregions and
produce a functional impairment in the behavioral response to
the D1-like agonist.
Ethanol-induced stimulation was tested. Selective knock-
down of Drd1 mRNA expression in the dorsal striatum dramati-
cally suppressed the acute ethanol stimulation at all doses,
causing a downward shift in the dose-response curve (Fig-
ure 7C). Littermate mice that received the control GFP vector
showed an unaltered stimulatory response to ethanol that
peaked at 2 g/kg (Figure 7C). No differenceswere found between
Cre-injected and GFP-injected mice on locomotion at 5–60 min
after ethanol administration (Figure 7E) or on the LORR test (Fig-
ure 7G), indicating that the sedative effects of ethanol were intact
after selective knockdown of Drd1 in the dorsal striatum.
In the ventral striatum, knockdown of Drd1 mRNA expression
had no effect on ethanol stimulation as the dose-response
curves overlapped (Figure 7D). Ethanol sedation was also intact,
as there were no statistical differences in the dose response
5–60 min following ethanol administration (Figure 7F).
These data indicate that activation of the dorsal striatum D1Rs
is required for ethanol stimulation and may play a role in ethanol
preference and drinking. Ethanol preference was tested using a
two-bottle choice test. Mice with decreased dorsal D1Rs
demonstrated a decreased preference for ethanol (Figure 7G),
while no differences in preference were noted in mice with a
knockdown of D1Rs in the ventral striatum. These data indicate
the importance of the dorsal striatal D1R in selectively modu-
lating the ethanol-induced stimulation and ethanol preference.
DISCUSSION
This study identifies a link between two well-known risk factors
for alcohol abuse in humans: low striatal D2R availability and
high sensitivity to the stimulatory effects of ethanol. We propose
that striatal D1R hypersensitivity is the substrate linking these
vulnerability factors. In a recent publication, we showed D1R hy-
persensitivity under conditions of low striatal D2Rs in medium(G) Locomotor activity measured in beam breaks/min before and after 2 g/kg e
pretreated with either saline (solid) or SCH-23390 (open; n = 12/group).
(H) SCH-23390 blocks ethanol-induced locomotion in a dose-dependent manne
effect of drug: F3,66 = 27.72 and genotype F1,22 = 15.01, p < 0.001 for both.
(I) No or little effect of SCH-23390 on locomotion after saline (2-way RMs ANOV
All of the symbols with error bars are means ± SEMs; symbols without error bars
1158 Cell Reports 29, 1147–1163, October 29, 2019spiny neurons (Dobbs et al., 2019). Here, we demonstrate that
this upregulation in D1Rs is functionally relevant, with D1Rs
driving ethanol stimulation. We also offer direct evidence that
low-D2R-expression iMSNs contribute to the vulnerability for
alcohol abuse by triggering D1R hypersensitivity, which in turn
drives the stimulatory effects of ethanol and renders mice insen-
sitive to the sedative effects of ethanol. It also promotes the pref-
erence for ethanol drinking and is associated with the escalation
in intake and compulsive-like drinking.
Mouse Models of Ethanol Stimulation Have Clinical
Relevance
Clinical studies indicate that individuals who drink heavily are
more sensitive to the stimulatory effects of ethanol and conse-
quently more prone to alcohol abuse (Erblich and Earleywine,
2003; Hendler et al., 2013; King et al., 2011, 2016). In mice, loco-
motor activity is used to examine the stimulatory properties of
drugs of abuse, including ethanol. Consistent with the literature,
our study finds that ethanol stimulation is short-lived and
followed by the onset of sedative effects (Pohorecky, 1977).
Furthermore, we found that mice with a high ethanol stimulatory
response show an enhanced ethanol preference. This, too, is
similar to the clinical condition in which higher perceived ethanol
stimulation is associated with a greater propensity toward
ethanol intake and abuse liability (Erblich and Earleywine,
2003; Holdstock et al., 2000; King et al., 2011, 2016).
We observed a great deal of individual variability in the stimu-
latory and sedative responses to ethanol within these inbred
mice, further indicating that genetics alone cannot account for
the differences. This suggests that environmental and epigenetic
factors play also an important role in this phenotype variability.
We also noted sex differences, with female mice showing
higher ethanol stimulation and increased ethanol intake when
normalized to body weight. These findings could be interpreted
as increased vulnerability for alcohol abuse in females. However,
in the human literature more men than women report using
alcohol and suffering from AUD (Substance Abuse and Mental
Health Services Administration, 2016). Non-biological factors,
such as reporting bias, differential access to alcohol, or age of
drinking onset, may be responsible for the opposing trends be-
tween humans and rodents.
There is a possibility that the sex differences could account for
the enhanced ethanol stimulation seen in iMSN-Drd2KO mice.
However, this seems unlikely because all of the experiments
were counterbalanced with sex as a variable, and female
iMSN-Drd2KO mice did not show higher stimulation than males.
Role of DA D2R in Vulnerability for Alcohol Abuse
Lower levels of striatal D2R availability have been associated
with addictive behaviors, including AUD. In humans, positron
emission tomography (PET) imaging studies show lower D2Rthanol in iMSN-Drd2KO (top, red) and littermate control (bottom, black) mice
r. Two-way RMs ANOVA drug dose 3 genotype: F3,66 = 3.72; **p < 0.01; main
A drug 3 genotype: F3,66 = 1.29, p > 0.05).
represent data from individual animals.
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availability in individuals who abuse alcohol (Volkow et al., 1996,
2002), and striatal D2R availability predicts how healthy subjects
perceive intoxication following alcohol exposure (Yoder et al.,
2005). In rodents, chronic alcohol consumption reduces striatal
D2R availability (Feltmann et al., 2018), and the overexpression
of D2Rs in alcohol-preferring rats causes a transient reduction
in ethanol preference and intake (Thanos et al., 2001). Thus, de-
cades of clinical and preclinical work support a link between low
striatal D2R levels, alcohol drinking, and preference.
In a transgenic mouse line with an extreme manipulation of
D2R levels (full D2RKO), ethanol stimulation is enhanced, while
sedation is absent (Palmer et al., 2003; Phillips et al., 1998; Ris-
inger et al., 2000). These findings suggested a causal link be-
tween D2R downregulation and ethanol-induced stimulation,
but the mechanism remained unknown, as a full knockout
does not allow for the discrimination of specific subpopulations
of striatal D2Rs contributing to the association/vulnerability.
By using transgenic mouse models with cell-type-specific
knockout of D2Rs, we were able to dissect out the contributions
of each population of D2Rs in ethanol-related behaviors and
vulnerability factors. This specific circuitry dissection is a benefit
of transgenic mouse lines. However, the use of transgenic mice
also adds the complexity of disentangling the acute effects of the
gene knockout and the developmental compensations.
In the present study, we found that micewith selective deletion
of D2Rs on striatal medium spiny neurons (iMSN-Drd2KO)
showed the greatest reduction in striatal D2R binding, have a
heightened stimulant response to ethanol, and are the most
resistant to the sedative effects of ethanol. When normalized,
iMSN-Drd2KO mice show a dramatic upward shift in ethanol
stimulatory response. When consulting the raw data, ethanol re-
stores movement in these mice, which have a consistent hypo-
locomotive phenotype. A valid interpretation of these findings
is that the actions of ethanol on D1R signaling are restoring loco-
motion to normal levels. iMSN-Drd2KO mice also exhibited an
increased preference for ethanol, higher rates of escalation of
ethanol drinking, and persistent drinking, despite adverse con-
sequences. Meanwhile, mice with targeted deletion of D2Rs on
striatal cholinergic interneurons or midbrain DA neurons showed
a modest reduction in striatal D2R binding and no significantFigure 7. Selective Knockdown of D1R Gene in Dorsal Striatum Ablate
(A) Fluorescent images of coronal brain sections showing the expression site of
8/group) of Drd1loxP/loxP mice. Scale bar, 1 mm.
(B) Levels of Drd1 mRNA normalized to the control gene in samples from dorsal
dorsal (left; n = 5–6/group) or ventral striatum (right; n = 3–4/group) of control vira
t test t(9) = 4.01; **p < 0.01 for dorsal samples of dorsal injections, t(6) = 3.43 for ve
injections; *p < 0.05; all of the samples were run in duplicate.
(C and D) Dose-dependent ethanol stimulation 5 min after ethanol administra
expression targeted to dorsal (C) or ventral (D) striatum. Two-way RMs ANOVA eth
Main effect of ethanol dose: F4,92 = 7.36, p < 0.0001, and viral injection: F1,23 =
injection: F4,64 = 0.51, p > 0.05.
(E and F) Dose-response curve for ethanol sedation, 5–60 min following ethanol a
(black) expression targeted to dorsal (E) or ventral striatum (F). Two-way RMs AN
0.68 for ventral injections, p > 0.05 for both.
(G) LORR duration in Drd1loxP/loxP mice that received control GFP or Cre-GFP vir
(H) Ethanol preference score in 2-bottle choice test for Drd1loxP/loxP mice, with Drd
mice that received a control vector (black). Independent sample t test: t(23) = 2.4;
6–14/group.
All of the symbols with error bars are means ± SEMs; symbols without error bars
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related behaviors. Because iMSN-Drd2KO mice show an
ethanol-induced stimulatory and sedative phenotype similar to
that of the global D2R knockout, we conclude that D2Rs specif-
ically on medium spiny neurons are driving the behavior.
While our findings provide direct evidence for a link between
low striatal D2Rs, ethanol stimulation, ethanol preference, and
escalation, iMSN-Drd2KO mice do not show a higher ethanol
intake in DID or self-administration compared to controls. It is un-
clear why this is the case, but it is possible that mice lacking me-
dium spiny neuron D2Rs are more sensitive to the reinforcing
properties of ethanol and therefore do not need to consume as
much to achieve the same intoxication state. The reference to
‘‘intoxication state’’ refers to mechanisms downstream of blood
ethanol levels, because we demonstrated that BECs are not
different across genotypes. An alternative explanation is that im-
pairments in learning are limiting the initial level of ethanol intake
in the operant self-administration task. The data indicate that
these mice can learn to self-administer ethanol and suggest
that given longer access periods, they could surpass littermate
controls in ethanol intake.
iMSN-Drd2KO mice also show higher resistance to the adul-
teration of ethanol with quinine and continue to drink despite
the averse taste. In ruling out a taste impairment and confirming
that the resistance to taste adulteration was selective for ethanol,
these findings could be interpreted as a sign of compulsive-like
drinking.
Changing the Balance of Striatal Circuitry Drives
Aberrant Ethanol Intake
Decades of research on basal ganglia circuit function and
models of Parkinson disease indicate that the balance between
the activity and signaling of D2R and D1R is critical for striatal cir-
cuitry function (Dobbs et al., 2017; Freeze et al., 2013; Gerfen
et al., 2002; Lobo and Nestler, 2011). Our previous findings indi-
cate that a selective reduction of D2Rs on iMSNs does not affect
striatal Drd1mRNA levels but rather leads to a functional upregu-
lation and signaling shift of striatal D1R (Dobbs et al., 2019).
Administration of a D1-like receptor agonist known to increase
downstream D1R targets, such as pGluA1 at serine-845 in thes Ethanol-Induced Stimulation
GFP-Cre in the dorsal (left; n = 12–14/group) and ventral striatum (right; n =
and ventral striatum of Drd1loxP/loxP mice that received intracranial injection in
l vector (black) or Cre-expressing vector (blue or purple). Independent sample
ntral samples of ventral injections, and t(5) = 3.21 for dorsal samples of ventral
tion in Drd1loxP/loxP mice with Cre-GFP (blue/purple) or control GFP (black)
anol dose3 viral injection: F4,92 = 2.63, *p < 0.05 for dorsal striatum injections.
5.07, p < 0.05. Ventral striatum injections 2-way RMs ANOVA ethanol dose 3
dministration, in Drd1loxP/loxP mice with Cre-GFP (blue/purple) or control GFP
OVA ethanol dose3 viral injection: F4,88 = 0.39 for dorsal injections and F4,64 =
al vectors in dorsal striatum. Independent sample t test: t(21) = 1.2, p > 0.05.
1 knockdown targeted to dorsal (blue, left) or ventral striatum (purple, right) and
*p < 0.05 for dorsal injections and t(17) = 0.7, p > 0.05 for ventral injections; n =
represent data from individual animals.
DMS, was confirmed in the present study. iMSN-Drd2KO mice
also show a robust increase in pGluA1 levels following ethanol,
indicating enhanced D1R activation following ethanol. Using a
viral knockdown approach, we further illustrated that D1Rs in
the DMS are necessary for driving the stimulatory actions of
ethanol.
D1R hypersensitivity is likely an adaptive response to the loss
of striatal D2Rs, whichwe previously showed causes an increase
in the GABAergic inhibition of D1R-expressing medium spiny
neurons in the striatum (Lemos et al., 2016). At the same time,
D1R hypersensitivity further disrupts the balance of D1R and
D2R activity. We propose here that this imbalance in striatal
D1R-D2R control of the circuitry generates abuse-vulnerable
circuitry in which individuals are more sensitive to ethanol stim-
ulation, and show ethanol preference, escalation, and compul-
sive-like use.
Concluding Remarks
These findings serve to settle a long-standing debate as to
whether low striatal D2Rs are a cause of alcohol consumption
(Everitt et al., 2008; Volkow and Baler, 2014). The present study
demonstrates that the manipulation of striatal D2R levels on
medium spiny neurons promotes ethanol-related phenotypes
associated with abuse in humans, suggesting that it is a key pre-
disposing factor for disordered alcohol intake.
The present study offers direct evidence that low levels of
striatal D2Rs promote ethanol stimulation via the functional upre-
gulation of D1R, which in turn drives maladaptive behaviors
toward alcohol. These mechanistic findings suggest that an
alteration of the balance of D1R-D2R activity promotes a state
of striatal circuitry that predisposes individuals to alcohol abuse.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
All procedures were performed in accordance with guidelines from the NIAAA Animal Care and Use Committee. For all experiments,
we usemale and female mice (C57Bl6J background, p45-150 at start of experiment) that were group-housed unless otherwise spec-
ified on 12h:12h light cycle (6:30am on, 6:30pm off) with standard rodent chow and water available ad libitum, unless otherwise
stated. All mouse lines used for breeding are commercially available and listed in Key Resources Table. Homozygous iMSN-Drd2KO
(Adora2a-Cre+/; Drd2loxP/loxP) mice were generated by crossing Drd2loxP/loxP mice, which carry the conditional allele for Drd2, with
Adora2a-Cre+/ mice, which express Cre recombinase under the adenosine 2a receptor promoter. Auto-Drd2KO (DatiresCre+/;
Drd2loxP/loxP) mice were generated by crossing Drd2loxP/loxP mice with DatiresCre+/mice, which express Cre recombinase under
the DAT promoter. Cin-Drd2KO mice were generated by crossing Drd2loxP/loxP mice with ChatiresCre+/ mice, which express Cre re-
combinase under the Chat promoter. For all experiments, Cre negative Drd2loxP/loxP littermates were used as controls. Drd1loxP/loxP
mice were used in viral vector injection studies. All mice were genotyped at weaning using real-time PCRwith their respective probes
by Transnetyx (Cordova, TN).
METHOD DETAILS
Outline of Experimental Design
Experiment 1: Control mice of the Drd2loxP/loxP line were tested on ethanol-induced locomotion using beam breaks. In order to
examine dose dependence mice were administered either saline or ethanol (0.5, 1.0, 2.0, 2.5 or 3.0 g/kg; 10 mL/kg) i.p. using
a Latin-square design over 6 consecutive days (Figures 1A–1C, S1A–S1D, and S2A–S2D). A subgroup of mice was also tested
on the LORR test 1 week after locomotion test ended (data presented in Figures 1D and 1E).
Experiment 2: Adora2a-Cre/ control mice from the Adora2a-Cre line were tested on the LORR, and then DID protocol (Figures
1E–1H, 1K, 1L, and S1E).
Experiment 3: A naive group of Drd2loxP/loxP mice were first tested on ethanol-induced locomotion and received either saline or
ethanol (2 g/kg). Mice were then tested for ethanol drinking preference for 3 days using the 2-bottle choice test and given access
to ethanol for 3 weeks using the DID protocol (Figures 1H–1J).
Experiment 4: Adora2a-Cre+/ mice and Adora2a-Cre/ littermate controls were tested on ethanol-induced locomotion and
mice received either saline or ethanol (2.5 g/kg; Figures S4A and S4B).
Experiment 5: Drd2 availability was analyzed in striatal tissue samples from naive Cin-Drd2KO, auto-Drd2KO and iMSN-Drd2KO
mice and littermate controls (n = 4-5/group) using radioligand binding (Figure 2).
Experiment 6: Cin-Drd2KO, auto-Drd2KO and iMSN-Drd2KO mice and their littermate controls were tested on the ethanol-
induced locomotion and mice were administered either saline or varying doses of ethanol (0.5, 1.0, 2.0, 2.5 or 3.0 g/kg,
10 mL/kg) i.p. using a Latin-square design (Figures 1A–1F and S3). The week following the locomotor testing, mice were tested
on LORR (Figures 3A, 3B, 3D, 3E, and 3G–3J). To measure ethanol metabolism, a separate group of Cin-Drd2KO, auto-Drd2KO
and iMSN-Drd2KO mice and littermate controls were injected with saline and ethanol, at varying doses (1.0, 2.0, or 3.0 g/kg;
10 mL/kg) i.p. using a Latin-square design and tail blood was obtained 5- and 60-minutes following injections and analyzed for
BEC (Figures 3C and 3F).
Experiment 7: Auto-Drd2KO and iMSN-Drd2KO mice and littermate controls were tested on ethanol-induced locomotion and
mice received either saline or ethanol (2 g/kg). Following locomotor testing,micewere tested for ethanol preference in a two-bottle
choice paradigm, and then allow access to ethanol for 3 weeks on a DID protocol (Figures 4A–4D, 4F, and 4G). Following DID,
mice were trained on the ethanol self-administration task (Figures 5A–5G). A separate group of auto-Drd2KO and iMSN-Drd2KO
mice and littermate controls were tested for sucrose preference using a two-bottle choice paradigm for 3 days (data in Figure 4G).
Experiment 8: control mice (Drd2loxP/loxP) were run on ethanol-induced locomotion test andmicewere pretreatedwith either saline
or naloxone (1 mg/kg) 15 min before receiving saline or ethanol (2 g/kg) using a counterbalanced design (Figure S7).
Experiment 9: iMSN-Drd2KOmice and littermate controls were run on ethanol-induced locomotion andmicewere pretreatedwith
either saline or 3 different doses of SCH-23390 (0.03, 0.075, 0.3 mg/kg) 15 min before receiving saline or ethanol (2 g/kg) using a
counterbalanced design (Figure 6).
Experiment 10: iMSN-Drd2KO and littermate control mice (n = 5-6/group) were administered i.p. saline, SKF-81297 (5 mg/kg) or
ethanol (2 mg/kg). Brains were harvested 15min later and the dorsomedial striatum (DMS) was dissected for protein level analysis
using the WES method (Figure 6).
Experiment 11: Drd1loxP/loxP mice were injected in the dorsal or ventral striatum with Cre-expressing or GFP-expressing control
viral vectors using stereotaxic methods. After 4 weeks, mice were tested on ethanol-induced locomotion and mice were admin-
istered either saline or ethanol (0.5, 1.0, 2.0, 2.5 or 3.0 g/kg, 10 mL/kg) i.p. using a Latin-square design (data presented in Figures
7C–7F). Mice were then tested on the ethanol drinking preference using a two-bottle choice paradigm (Figure 7G). Mice with viral
injections in the dorsal striatumwere further tested on the LORR (Fig H-1). At the completion of all behavioral studies, striatia wereCell Reports 29, 1147–1163.e1–e5, October 29, 2019 e2
dissected for confirmation of viral injection targeting using fluorescence visualization of viral expression. Drd1 expression was
quantified in a subgroup of mice using qPCR (Figure 7B).
Behavioral Testing
Ethanol-Induced Locomotion
Naive mice (6-20 weeks old) were used for all experiments. Sample size determination sufficient for the detection of between-group
differences was based on previous data from our laboratory. On average, 6 mice per sex/per group/ genotype were used. Testing
was done during the light phase of the cycle. Mice were transferred to the experimental room and acclimated for 1 h before they
were placed in polycarbonate chambers (20 cm H x 17 cm W x 28 cm D) equipped with infrared photobeam detectors (Columbus
Instruments). Beam breaks were recorded for 1 h for habituation to locomotor chambers before mice received i.p. injections and
beam breaks were recorded for an additional hour. Mice received saline 10 mL/kg, i.p. for days 1-3 in order to habituate to handling
and injections. Subsequent days, during the testing phase, mice were administered either saline or ethanol (0.5, 1.0, 2.0, 2.5 or 3.0
g/kg, 10 mL/kg) i.p. using a Latin-square design over 6 consecutive days. When testing antagonists, mice were habituated to the
chambers for 1 h as before. They received pretreatment with either saline or antagonist (10mL/kg, i.p.). 15min before receiving either
ethanol (2 g/kg) or saline and beam breaks were recorded for an additional hour.
Loss of Righting Reflex
Mice were transferred to the experimental room and acclimated for 1 h before they were injected with ethanol (3.5 g/kg, 10 mL/kg,
i.p.) and placed supine in a v-shaped trough. The time to lose the righting-reflex was defined as the time from injection to when the
mouse showed an inability to right itself within a 30 s time interval, was recorded. Themicewere then left undisturbed until they began
to regain the righting reflex (flip themselves over unaided). Once themouse self-rights, it is again placed supine.When themouse can
self-right three timeswithin 30 s, the time of righting is recorded. The LORR timewas defined as the time between losing the reflex and
regaining it. Tail blood samples were immediately obtained following righting or at the termination of the study for BEC measure-
ments. After 90 minutes, if a mouse did not lose its righting reflex, the experiment was terminated, and blood samples were obtained
for BEC measurements.
Two-Bottle Preference Test for Ethanol-, Sucrose-, or Quinine-Adulterated Water
Mice were singly housed and for three days had ad libitum access to rodent chow, water, and test solution (either 1% sucrose (w/v),
20% ethanol (v/v) or water adulterated with quinine (0.5 mM or 1 mM)). Concentrations were selected based on the literature and
previous studies (Hwa et al., 2011; Lewis et al., 2005). The test solution was prepared by diluting sucrose (Sigma-Aldrich) or 95%
alcohol (190 proof, stored in glass, Deacon Labs) in tap water. Solutions were presented in glass tubes (253 100 mm, Pyrex) fitted
with straight, open-tippedmetal sippers. Glass tubes were weighed every 24 hours to determine intake, and the position of the water
and test solution tubes were switched. Procedure was repeated daily for 4 days. Preference was calculated as the ratio of the volume
of test solution consumed divided by the total volume consumed in 24 hours and averaged for the final 3 days.
Drinking-in-the-Dark (DID) Procedure
Mice were acclimated to being singly-housed in a reversed-light-cycle room for at least one week before the start of the experiment.
Three hours into the dark cycle, water bottles were replaced with bottles containing 20% ethanol (v/v). Four hours later, alcohol bot-
tles were removed, and water bottles were returned to the cage. Intake was determined by change in bottle weight. Food was avail-
able ad libitum. This procedure was repeated 5 days per week, for 3 weeks. Blood ethanol concentrations (BECs) were determined
twice a week.
Blood Ethanol Concentration (BEC) Measurements
Blood samples were collected twice a week, immediately following DID sessions. The tail vein was nicked with a razor blade and
15–50 mL of blood was collected in heparinized capillary tubes. Tubes were centrifuged for 5 min, and plasma was isolated. BECs
in plasma samples were analyzed in duplicate using the Analox analyzer GM7 MicroStat (Analox Instruments, Lunenburg, MA).
Operant Self-Administration
The SIPPER training procedure was adapted from Blegen et al. (2018). Mice were pre-exposed to 3 weeks of modified DID in their
home cages as described above. Mice were then trained to self-administer ethanol (20% v/v) in operant chambers (Med Associates).
Each chamber is fitted with two levers (active and inactive), a cue light and a retractable lixit sipper and is housed in a sound-atten-
uating boxwith a ventilation fan. The retractable sipper is attached to a 5ml glass pipette containing the ethanol solution, which allows
for precisemeasurements of the volume consumed. A lickometer attached to the sipper records contacts. Presses on the active lever
result in sipper extension into the chamber, providing 1 min of access to the ethanol solution. Presses on the inactive lever are re-
corded but have no consequence. The cue light located above the active lever is illuminated as default and it turns off after lever press
and while the sipper is extended. Acquisition of operant behavior began with 3 intermittently spaced days of 6h training sessions
during which each active lever press resulted in an alcohol access period (FR1). As training progressed, session length is shortened
to 2 h, 5 days aweek, at FR1. After 12 sessions at these parameters, holding all other variables constant, the fixed ratio was increased
to 3 (FR3) for the final 3 days of training. A food pellet was made available in the operant chamber. Because of no significant sex
differences in operant behaviors, the data from males and females were collapsed. Data are presented as responding or intake
per session.e3 Cell Reports 29, 1147–1163.e1–e5, October 29, 2019
Quinine Adulteration
Ethanol consumption despite negative consequences was measured as persistence of drinking after ethanol was adulterated with
bitter tasting quinine. Following the third day of the FR3 training session, ethanol was adulterated during two consecutive days with
increasing doses of quinine (0.5 and 1mM) and operant responses and ethanol consumption were recorded. Quinine adulteration
sessions were 2 h long at FR3.
Ethanol-Seeking Test
After quinine adulteration, mice were kept in their home cages for 23 days in a forced ethanol abstinence period with ad libitum ac-
cess to water and food. After abstinence, mice were brought back to the operant chambers and tested for ethanol seeking behavior.
The ethanol seeking session was similar to the late operant training sessions (lasting 2h, FR3), with one change.When the active lever
was pressed, the sipper was presented for 1 min, but no solution was made available. The number of presses and number of licks
were recorded.
Relapse Test
Following the seeking test, micewere housed in their home cages for 18 days with ad libitum access to water and food. After a total of
41 days of forced ethanol abstinence, mice were tested on a relapse test. They were allowed to self-administer ethanol for 6h at FR3.
Alcohol intake, lever presses and licks were recorded.
Classification Criteria
Using unsupervised hierarchical cluster analysis, mice were classified into distinct groups based on their daily alcohol intake during
the 2-hour training sessions (16 sessions in total). A pairwise distance matrix of the square of the difference of the daily alcohol intake
was calculated and used as the input data to generate an unsupervised hierarchical cluster. Agglomerative hierarchical clustering
was generated according to the Ward’s minimum variance criterion using the function hclust from the basic stats package of the
R software (version 3.4.2) and the optimal number of clusters was defined according to multiscale bootstrap resampling (n =
1000, alpha = 95%) using the pv.clust function from the pv.clust package. The best-fit tree was plotted using the ggplot2 package.
Stereotaxic Viral Injection
Mice were placed in a stereotaxic frame under isoflurane anesthesia and bilaterally infused with a viral vector expressing Cre
(AAV9.CMV.HI.eGFP-Cre.WPRE.SV40; U Penn) or a control vector (AAV2/9.CB7.CI.EGFP.RBG, U Penn) into the ventral or dorsal
striatum. Viral injections (200 nL/injection) were delivered at a rate of 100 nL/min and the injection needle was kept in place for
4 min following the infusion to promote proper diffusion and prevent backflow. Stereotaxic coordinates for the ventral striatum
were (mm from bregma): +1.4 AP, ± 1.2 ML, 5.0 DV. Stereotaxic coordinates for the dorsal striatum were: +0.5, +1.0 AP, ± 1.5,
± 1.75 ML, 3.75 DV. Behavioral experiments began 4 weeks after viral injections. Viral expression was confirmed by fluorescence
visualization and qPCR.
Quantitative Polymerase Chain Reaction
Mice were anesthetized with pentobarbital and decapitated. Brains were removed, and the striatum was dissected on ice using a
1mm coronal matrix, placed in RNAlater, homogenized, and total RNA was purified using RNeasy Plus Mini kit (QIAGEN). cDNA
was synthesized using iScript Reverse Transcription Supermix (Biorad). Actb (Mm01205647) and Drd1 (Mm02620146_s1) TaqMan
Gene Expression Assays (Applied Biosystems) were used to determine relative mRNA expression of the endogenous control gene
b-actin and DA D1Rs, respectively. Samples were run in triplicate and in parallel with negative controls using the StepOnePlus Real-
Time PCR system (Applied Biosystems). The cycling conditions were: initial hold at 95C (20 s), 40 cycles of 95C (1 s) and 60C (20 s).
Relative D1 receptor expression was calculated using the DDCt method.
Radioligand Binding Assays
D2 receptor expression in mouse striata was measured using radioligand binding saturation assays. To decrease variability, striata
from littermate-paired male mice were used. Mice were deeply anesthetized with isoflurane, brains were extracted, the striatum was
rapidly dissected on ice and immediately frozen until further processed. Striata were lysed in Dounce homogenizers using 5mMTris-
HCl and 5 mM MgCl2 at pH 7.4 and 4
C. The resulting membranes were pelleted by centrifugation at 30,000 x g for 30 minutes and
then were resuspended in 50 mM Trizma at pH 7.4 and 4C. Membrane preparations (400 mL) were added to 500 mL of the indicated
concentrations of [3H]-methylspiperone (PerkinElmer, Waltham,MA) plus 100 mL of buffer or drugs for a final reaction volume of 1mL.
Binding was carried out in the presence of 50 nM ketanserin to block binding to 5-HT2-like receptors (Hamblin et al., 1984). Non-spe-
cific binding was determined in the presence of 4 mM (+)-butaclamol. After a 90 min incubation at room temperature, bound ligand
was separated from free by filtration through Whatman GF/B filter paper pretreated with 0.3% polyethyleneimine using a Brandel
Harvester (Brandel, Gaithersburg, MD). Filter paper was washed 3 times in ice-cold 50 mM Trizma buffer. After drying, filter paper
samples were punched in to scintillation vials and mixed with 3 mL ScintiVerse BD Cocktail. Radioactivity bound to the filters was
counted with a Beckman LS6500 scintillation counter.
Capillary Electrophoresis
Mice were administered either SKF-81297 (5 mg/kg), saline or ethanol (2 g/kg) i.p. 15 minutes later they were anesthetized with
pentobarbital and the dorsal medial striatum was rapidly dissected on ice. The DMS was dissected between +1.18 and +
0.74mm anterior from bregma,2.25 to3.75 mm below brain surface and ± 0.75 to 1.25 mmmedial frommidline. Tissue was flash
frozen in liquid nitrogen and stored at 80C until homogenized in ice cold RIPA buffer (ThermoScientific) spiked with Halt protease
and phosphatase inhibitor cocktail (ThermoScientific). Protein amounts in the supernatant were quantified using the Pierce BCA
assay (ThermoScientific), aliquoted, and frozen at –80C. Capillary electrophoresis was performed using the fully automated WesCell Reports 29, 1147–1163.e1–e5, October 29, 2019 e4
system (ProteinSimple) following the manufacturer’s recommendations. Briefly, 2 mg/mL of protein lysate were mixed with the fluo-
rescent master mix. The samples and protein standard were denatured for 5 min at 95C. Samples were loaded into 12- to 250-kDa
separation matrix microplates (ProteinSimple) containing blocking buffer, primary and secondary antibodies, and wash buffer for
automated, sequential processing. The chemiluminescence based electrophoretogram was auto generated and area under the
chemiluminescent peaks was determined using Compass software (ProteinSimple). All samples were run in duplicate across micro-
plates. Primary antibodies were rabbit anti-glutamate receptor 1, phosphoSer 845 (1:25; Millipore #AB5849), rabbit anti-glutamate
receptor 1 (1:50; Abcam #109450) andmouse anti-GAPDH (1:2000; Ambion #AM4300). HRP-conjugated secondary anti-mouse and
anti-rabbit antibodies (ProteinSimple) were used at the predefined concentrations provided by the manufacturer.
Drugs
Ethanol (Decon Laboratories, 190 proof, in glass container) was dissolved in tap water at 20% v/v. Quinine (Sigma-Aldrich) was
dissolved in 20% alcohol. SCH-23390 (abcam) and SKF-81297 (hello bio) were dissolved in saline. Intraperitoneal (i.p.) drug admin-
istration was delivered at 10 ml/kg body weight.
QUANTIFICATION AND STATISTICAL ANALYSIS
Analyses were performed in Prism 7 (GraphPad). All statistical analysis is presented in the figure legends. Data from ethanol induced
locomotion, blood ethanol concentrations, loss of righting reflex, preference testing, drinking in the dark, ethanol self-administration,
and dopamine radioligand binding were analyzed using two-way ANOVA, with the addition of repeated-measures (RM) as appro-
priate. Significant main effects or interactions were followed-up with pairwise tests corrected for multiple comparisons. Paired or in-
dependent sample t test was used to analyze remainder of data. Results were considered significant at an alpha% 0.05. All data are
presented as mean ± SEM. Sample sizes were chosen based on previous research employing similar approaches and are sufficient
for detecting strong effect sizes while using the minimal number of animals.
DATA AND CODE AVAILABILITY
This study did not generate code. The datasets supporting the current are available from the corresponding author on request.e5 Cell Reports 29, 1147–1163.e1–e5, October 29, 2019
